Avantax Advisory Services, Inc. Novavax Inc Transaction History

Avantax Advisory Services, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$36.28 - $75.29 $106,880 - $221,804	-2,946 Closed	0 $0
Q1 2022 Apr 27, 2022	SELL	$69.73 - $142.9 $152,081 - $311,664	-2,181 Reduced 42.54%	2,946 $218,000
Q4 2021 Jan 24, 2022	BUY	$134.56 - $217.97 $81,274 - $131,653	604 Added 13.35%	5,127 $734,000
Q3 2021 Oct 21, 2021	BUY	$177.8 - $270.58 $64,363 - $97,949	362 Added 8.7%	4,523 $932,000
Q2 2021 Jul 29, 2021	BUY	$121.0 - $257.67 $125,356 - $266,946	1,036 Added 33.15%	4,161 $881,000
Q1 2021 May 13, 2021	BUY	$112.98 - $319.93 $48,242 - $136,610	427 Added 15.83%	3,125 $569,000
Q4 2020 Jan 22, 2021	SELL	$78.74 - $139.5 $663,778 - $1.18 Million	-8,430 Reduced 75.75%	2,698 $302,000
Q3 2020 Oct 14, 2020	BUY	$79.44 - $178.51 $884,008 - $1.99 Million	11,128 New	11,128 $1.2 Million

288

94.7M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $680M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Avantax Advisory Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Avantax Advisory Services, Inc. with notifications on news.